HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS

The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: YARLAGADDA, SURESH, ROAYAPALLEY, PRAVEEN KUMAR, MOHAMMED, ABDUL RASHEED, JAYARAJAN, PRADEEP, RAVELLA, SRINIVASA RAO, JASTI, VENKATESWARLU, NIROGI, RAMAKRISHNA, KAMBHAMPATI, RAMASASTRI, PATNALA, SRIRAMACHANDRA MURTHY, SHINDE, ANIL KARBHARI, BHYRAPUNENI, GOPINADH, RAVULA, JYOTHSNA
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator YARLAGADDA, SURESH
ROAYAPALLEY, PRAVEEN KUMAR
MOHAMMED, ABDUL RASHEED
JAYARAJAN, PRADEEP
RAVELLA, SRINIVASA RAO
JASTI, VENKATESWARLU
NIROGI, RAMAKRISHNA
KAMBHAMPATI, RAMASASTRI
PATNALA, SRIRAMACHANDRA MURTHY
SHINDE, ANIL KARBHARI
BHYRAPUNENI, GOPINADH
RAVULA, JYOTHSNA
description The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptors. La présente invention concerne, d'une part de nouveaux composés représentés par la formule (I), d'autre part leurs sels pharmaceutiquement admis, et enfin des compositions les contenant. L'invention concerne également un procédé d'élaboration de ces composés et de leurs sels pharmaceutiquement admis. Les composés représentés par la formule (I) conviennent au traitement de divers troubles dans lesquels interviennent les récepteurs 5-HT4.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2823548C</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2823548C</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2823548C3</originalsourceid><addsrcrecordid>eNrjZNDzcA1xDfJ3DIr0UXD29w3wD_VzCVZwDFYw1fUIMVEIcnV2DQjxD1Lw8XR3BMrwMLCmJeYUp_JCaW4GeTfXEGcP3dSC_PjU4oLE5NS81JJ4Z0cjCyNjUxMLZ2PCKgBGtiS-</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS</title><source>esp@cenet</source><creator>YARLAGADDA, SURESH ; ROAYAPALLEY, PRAVEEN KUMAR ; MOHAMMED, ABDUL RASHEED ; JAYARAJAN, PRADEEP ; RAVELLA, SRINIVASA RAO ; JASTI, VENKATESWARLU ; NIROGI, RAMAKRISHNA ; KAMBHAMPATI, RAMASASTRI ; PATNALA, SRIRAMACHANDRA MURTHY ; SHINDE, ANIL KARBHARI ; BHYRAPUNENI, GOPINADH ; RAVULA, JYOTHSNA</creator><creatorcontrib>YARLAGADDA, SURESH ; ROAYAPALLEY, PRAVEEN KUMAR ; MOHAMMED, ABDUL RASHEED ; JAYARAJAN, PRADEEP ; RAVELLA, SRINIVASA RAO ; JASTI, VENKATESWARLU ; NIROGI, RAMAKRISHNA ; KAMBHAMPATI, RAMASASTRI ; PATNALA, SRIRAMACHANDRA MURTHY ; SHINDE, ANIL KARBHARI ; BHYRAPUNENI, GOPINADH ; RAVULA, JYOTHSNA</creatorcontrib><description>The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptors. La présente invention concerne, d'une part de nouveaux composés représentés par la formule (I), d'autre part leurs sels pharmaceutiquement admis, et enfin des compositions les contenant. L'invention concerne également un procédé d'élaboration de ces composés et de leurs sels pharmaceutiquement admis. Les composés représentés par la formule (I) conviennent au traitement de divers troubles dans lesquels interviennent les récepteurs 5-HT4.</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20151027&amp;DB=EPODOC&amp;CC=CA&amp;NR=2823548C$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20151027&amp;DB=EPODOC&amp;CC=CA&amp;NR=2823548C$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YARLAGADDA, SURESH</creatorcontrib><creatorcontrib>ROAYAPALLEY, PRAVEEN KUMAR</creatorcontrib><creatorcontrib>MOHAMMED, ABDUL RASHEED</creatorcontrib><creatorcontrib>JAYARAJAN, PRADEEP</creatorcontrib><creatorcontrib>RAVELLA, SRINIVASA RAO</creatorcontrib><creatorcontrib>JASTI, VENKATESWARLU</creatorcontrib><creatorcontrib>NIROGI, RAMAKRISHNA</creatorcontrib><creatorcontrib>KAMBHAMPATI, RAMASASTRI</creatorcontrib><creatorcontrib>PATNALA, SRIRAMACHANDRA MURTHY</creatorcontrib><creatorcontrib>SHINDE, ANIL KARBHARI</creatorcontrib><creatorcontrib>BHYRAPUNENI, GOPINADH</creatorcontrib><creatorcontrib>RAVULA, JYOTHSNA</creatorcontrib><title>HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS</title><description>The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptors. La présente invention concerne, d'une part de nouveaux composés représentés par la formule (I), d'autre part leurs sels pharmaceutiquement admis, et enfin des compositions les contenant. L'invention concerne également un procédé d'élaboration de ces composés et de leurs sels pharmaceutiquement admis. Les composés représentés par la formule (I) conviennent au traitement de divers troubles dans lesquels interviennent les récepteurs 5-HT4.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNDzcA1xDfJ3DIr0UXD29w3wD_VzCVZwDFYw1fUIMVEIcnV2DQjxD1Lw8XR3BMrwMLCmJeYUp_JCaW4GeTfXEGcP3dSC_PjU4oLE5NS81JJ4Z0cjCyNjUxMLZ2PCKgBGtiS-</recordid><startdate>20151027</startdate><enddate>20151027</enddate><creator>YARLAGADDA, SURESH</creator><creator>ROAYAPALLEY, PRAVEEN KUMAR</creator><creator>MOHAMMED, ABDUL RASHEED</creator><creator>JAYARAJAN, PRADEEP</creator><creator>RAVELLA, SRINIVASA RAO</creator><creator>JASTI, VENKATESWARLU</creator><creator>NIROGI, RAMAKRISHNA</creator><creator>KAMBHAMPATI, RAMASASTRI</creator><creator>PATNALA, SRIRAMACHANDRA MURTHY</creator><creator>SHINDE, ANIL KARBHARI</creator><creator>BHYRAPUNENI, GOPINADH</creator><creator>RAVULA, JYOTHSNA</creator><scope>EVB</scope></search><sort><creationdate>20151027</creationdate><title>HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS</title><author>YARLAGADDA, SURESH ; ROAYAPALLEY, PRAVEEN KUMAR ; MOHAMMED, ABDUL RASHEED ; JAYARAJAN, PRADEEP ; RAVELLA, SRINIVASA RAO ; JASTI, VENKATESWARLU ; NIROGI, RAMAKRISHNA ; KAMBHAMPATI, RAMASASTRI ; PATNALA, SRIRAMACHANDRA MURTHY ; SHINDE, ANIL KARBHARI ; BHYRAPUNENI, GOPINADH ; RAVULA, JYOTHSNA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2823548C3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YARLAGADDA, SURESH</creatorcontrib><creatorcontrib>ROAYAPALLEY, PRAVEEN KUMAR</creatorcontrib><creatorcontrib>MOHAMMED, ABDUL RASHEED</creatorcontrib><creatorcontrib>JAYARAJAN, PRADEEP</creatorcontrib><creatorcontrib>RAVELLA, SRINIVASA RAO</creatorcontrib><creatorcontrib>JASTI, VENKATESWARLU</creatorcontrib><creatorcontrib>NIROGI, RAMAKRISHNA</creatorcontrib><creatorcontrib>KAMBHAMPATI, RAMASASTRI</creatorcontrib><creatorcontrib>PATNALA, SRIRAMACHANDRA MURTHY</creatorcontrib><creatorcontrib>SHINDE, ANIL KARBHARI</creatorcontrib><creatorcontrib>BHYRAPUNENI, GOPINADH</creatorcontrib><creatorcontrib>RAVULA, JYOTHSNA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YARLAGADDA, SURESH</au><au>ROAYAPALLEY, PRAVEEN KUMAR</au><au>MOHAMMED, ABDUL RASHEED</au><au>JAYARAJAN, PRADEEP</au><au>RAVELLA, SRINIVASA RAO</au><au>JASTI, VENKATESWARLU</au><au>NIROGI, RAMAKRISHNA</au><au>KAMBHAMPATI, RAMASASTRI</au><au>PATNALA, SRIRAMACHANDRA MURTHY</au><au>SHINDE, ANIL KARBHARI</au><au>BHYRAPUNENI, GOPINADH</au><au>RAVULA, JYOTHSNA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS</title><date>2015-10-27</date><risdate>2015</risdate><abstract>The present invention relates to novel compounds of formula (I), and their pharmaceutically acceptable salts and compositions containing them. The present invention also relates to a process for the preparation of above said novel compounds, and their pharmaceutically acceptable salts. The compounds of formula (I) are useful in the treatment of various disorders that are related to 5-HT4 receptors. La présente invention concerne, d'une part de nouveaux composés représentés par la formule (I), d'autre part leurs sels pharmaceutiquement admis, et enfin des compositions les contenant. L'invention concerne également un procédé d'élaboration de ces composés et de leurs sels pharmaceutiquement admis. Les composés représentés par la formule (I) conviennent au traitement de divers troubles dans lesquels interviennent les récepteurs 5-HT4.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2823548C
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title HETEROARYL COMPOUNDS AS 5-HT4 RECEPTOR LIGANDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A16%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YARLAGADDA,%20SURESH&rft.date=2015-10-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2823548C%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true